source
- Agenus redirects late-stage colorectal trial to pre-surgery setting, shares double; Oxford Ebola vaccine enters Phase 1Agenus announced it will stop financially supporting its late-stage trial of the BOT+BAL immunotherapy combination in late-line colorectal cancer. The company will instead use recent $340 million…
- States' Medicaid cuts threaten financial stability of family caregivers for disabled adultsSeveral states are proposing steep reductions in wages for family caregivers who provide care to people with disabilities as they grapple with Medicaid funding shortfalls. The article highlights t…